DexCom, Inc. (DXCM) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Stay updated on DexCom, Inc. (DXCM) stock with short-term forecast for year 2025 and long-term price prediction for 2025 - 2050. Access historical performance, see analyst ratings, and follow the latest DexCom, Inc. news and developments.
1 Month Prediction
$215.69 [142.16%]
3 Month Prediction
$193.24 [116.95%]
6 Month Prediction
$141.32 [58.66%]
1 Year Prediction
$146.68 [64.68%]
3 Year Prediction
$50.09 [-43.76%]
5 Year Prediction
$1.00 [-98.88%]
About DexCom, Inc.
Dexcom, Inc., founded in 1999, is a medical device company based in San Diego, California. It designs and develops continuous glucose monitoring (CGM) systems for diabetes management.
Their product includes Dexcom G6 and G7 CGM systems, which provide real-time glucose monitoring for individuals with diabetes. The company introduced Stelo, an over-the-counter CGM designed for non-insulin users.
Dexcom sells directly in the US, Austria, Canada, Germany, Switzerland, and the UK. They also use distributors to sell in Australia, New Zealand, Asia, Europe, Africa, Latin America, and the Middle East.
DexCom, Inc. (DXCM) Historical Performance
IPO Date
DexCom, Inc. (NASDAQ:DXCM) went public on 14 April, 2005.
Change
Since inception, DXCM has increased by 3,462.80%. In the last 5 years, DXCM has risen from $67.32 to $89.07, a massive 32.31% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $155.80 and a low of $67.04.
52 Week Range
$62.34
$142.0
The current price $89.07 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
DXCM Stock Price History
Based on DXCM stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the DXCM stock has risen from $60.19 - $108.89 to $86.83 - $89.07, which is up 121.35%. Currently, the stock follows upward trend.
Here, we have calculated stock range of DXCM, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $60.19 - $108.89 | $87.23 | 119.54 | 1 Year Change |
| 2021 | $89.85 - $155.8 | $117.27 | 195.15 | 2 Year Change |
| 2022 | $74.49 - $127.9 | $98.77 | 148.58 | 3 Year Change |
| 2023 | $88.83 - $128.51 | $112.39 | 182.86 | 4 Year Change |
| 2024 | $67.04 - $138.7 | $97.09 | 144.36 | 5 Year Change |
| 2025 | $86.83 - $89.07 | $87.95 | 121.35 | 6 Year Change |
DXCM Price Performance
6-Month Performance
DXCM stock jumped by 32.86% in the last six months.
1-Year Performance
The stock has trended downwards by 35.78% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 30.36%.
5-Year Performance
In the last 5 years, the stock has gone up by 32.31%.
According to DexCom, Inc.'s historical data, below graph gives us the exact picture of how the DXCM stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
69.02% ↑
2021
45.23% ↑
2022
15.64% ↓
2023
9.58% ↑
2024
37.33% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
DexCom, Inc. (DXCM) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $994.20 M (Q3)
Revenue for Q3 ending 30th September, 2024 decreased 1.01% compared to Q2 ending 30th June, 2024.
Annual Revenue: $3.95 B (1Y)
Revenue for trailing 12 months increased 9.16% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $1.93 billion to $3.95 billion, a 105.22% change.
Market Capitalization
DexCom, Inc. has a market capitalization of $34.80B, which places DXCM in the large-cap category.
Fundamental Analysis
EPS: $0.34 (Q3), $1.40 (1Y)
EPS decreased 5.56% since last quarter, and increased 59.09% since last year.
Net Income: $134.60 M (Q3), $541.50 M (1Y)
Net Income decreased 6.20% since last quarter, and increased 58.70% since last year.
Free Cash Flow: $88.30 M (Q3), $511.90 M (1Y)
Free Cash Flow decreased 58.60% since last quarter, and increased 68.00% since last year.
Net Profit Margin: 13.54% (Q3), 13.69% (1Y)
Net Profit Margin decreased 5.25% since last quarter, and increased 45.39% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for DXCM stock. These indicators help you understand DexCom, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for DXCM stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $87.12 |
| SMA50 | $82.36 |
| SMA200 | $88.29 |
| RSI | 54.49 |
| Beta | 1.14 |
SMA20 < Current Price
This signals DXCM stock is in short-term bullish momentum.
SMA50 < Current Price
This signals DXCM stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals DXCM stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for DXCM stock is Bullish. Out of all indicators, 4 indicates bullish signals, 3 signals bearish trends and 2 gives neutral trends. The DXCM stock forecast was last updated on 17 February, 2025.
DexCom, Inc. (DXCM) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $156.86 by the end of 2025, and can reach around $223.38 to $155.81 in 2026. And, the long-term forecast suggests that the stock may further drop to $97.62 - $59.45 in 2028, and $0.85 - $0.96 by 2031. So, the DXCM stock shows a strong upward trend in the next several years.
Short-term DXCM Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $215.69 | 142.16% |
| 2025-04 | $202.87 | 127.76% |
| 2025-05 | $193.24 | 116.95% |
| 2025-06 | $187.71 | 110.74% |
| 2025-07 | $141.52 | 58.89% |
| 2025-08 | $141.32 | 58.66% |
| 2025-09 | $139.25 | 56.34% |
| 2025-10 | $129.38 | 45.26% |
| 2025-11 | $151.68 | 70.29% |
| 2025-12 | $156.86 | 76.11% |
In 2025, the DXCM stock price is expected to fluctuate between $129.38 and $215.69. According to the monthly forecast, the stock could rise to $156.86 by December 2024. If compared to the DXCM's current price, the stock could gain 76.11% by the end of this year.
Long-term DXCM Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $223.38 | $135.72 | $155.81 | 74.93% |
| 2027 | $133.75 | $115.32 | $105.92 | 18.92% |
| 2028 | $97.62 | $57.50 | $59.45 | -33.25% |
| 2029 | $39.16 | $8.68 | $8.88 | -90.03% |
| 2030 | $0.96 | $0.93 | $1.17 | -98.69% |
| 2031 | $0.85 | $0.94 | $0.96 | -98.92% |
| 2032 | $0.66 | $1.10 | $1.04 | -98.83% |
| 2033 | $1.17 | $0.99 | $0.98 | -98.9% |
| 2034 | $0.97 | $1.04 | $1.05 | -98.82% |
| 2035 | $0.85 | $0.90 | $0.62 | -99.3% |
| 2036 | $0.94 | $1.06 | $1.11 | -98.75% |
| 2037 | $1.18 | $0.91 | $1.09 | -98.78% |
| 2038 | $1.08 | $1.01 | $1.04 | -98.83% |
| 2039 | $1.02 | $0.86 | $0.94 | -98.94% |
| 2040 | $1.05 | $1.08 | $0.94 | -98.94% |
| 2041 | $1.00 | $1.00 | $1.03 | -98.84% |
| 2042 | $0.84 | $0.92 | $0.84 | -99.06% |
| 2043 | $1.16 | $0.96 | $1.08 | -98.79% |
| 2044 | $0.98 | $0.84 | $0.98 | -98.9% |
| 2045 | $1.03 | $1.25 | $0.94 | -98.94% |
| 2046 | $1.10 | $1.07 | $0.87 | -99.02% |
| 2047 | $1.05 | $1.02 | $0.75 | -99.16% |
| 2048 | $0.82 | $1.04 | $1.02 | -98.85% |
| 2049 | $1.12 | $1.06 | $1.02 | -98.85% |
| 2050 | $0.91 | $1.13 | $0.79 | -99.11% |
| 2051 | $1.13 | $0.90 | $1.18 | -98.68% |
DexCom, Inc. (DXCM) Stock Price Prediction & Forecast 2025
At the start of 2025, the DXCM stock was at $86.83. Today, it is trading at $89.07, which is 2.58% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $156.86 by December 2025 with a 76.11% change.
DexCom, Inc. (DXCM) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the DXCM stock. During this period, the DXCM's price is forecasted to shift from $223.38 to $1.17, which is -99.48% loss.
In 2026, the stock would possibly open at $223.38, descends to $135.72 by mid-year, and wraps up at $155.81, reflecting a 74.93% increase from today's price. Further moving to 2030, the stock can kick off the year at $0.96, drop to $0.93 by mid-year, and finish at $1.17, which is -98.69% change from current price.
DexCom, Inc. (DXCM) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.85 to $0.94, which is up -98.92%
In 2031, we can expect DXCM to fluctuate between $0.85 and $0.96, a shift indicating a -98.92% loss by year-end compared to current price. And Until 2040, DXCM can likely vary from $0.94 to $1.05. By the end of 2040, the stock could record a -98.95% fall from today's stock price.
DexCom, Inc. (DXCM) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the DXCM stock can see an a downturn from $1.00 to $0.79 in this period. In 2041, the stock can experience a low of $1.00 by mid-year, closing the year at $1.03. This results in a -98.88% decrease from today.
Moving towards the end of 2050, DXCM is projected to open the year at $0.91. The stock may peak to $1.13 during mid-year and finish the year at $0.79. Compared to the stock's current price, this translates to an overall loss of -99.11% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
DXCM Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| TIVC | Tivic Health Systems, Inc. | - | $0.69 | 194.32% ▲ | $43.97 ▲ |
| QSI | Quantum-Si incorporated | - | $2.24 | -17.04% ▼ | $35.85 ▲ |
| BMRA | Biomerica, Inc. | - | $0.64 | 113.33% ▲ | $56.25 ▲ |
| INBS | Intelligent Bio Solutions Inc. | - | $2.49 | 41.48% ▲ | -59.84 ▼ |
| SENS | Senseonics Holdings, Inc. | - | $1.04 | 8.22% ▲ | -3.85 ▼ |
Last updated Feb 17 at 2:55 PM
DXCM : Buy, Sell Or Hold?
Analyst Ratings
Based on 25 analysts, 3 rated as a strong buy, 18 recommended a buy, 4 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 23 analysts, 5 analysts gave a strong buy rating, 13 a buy rating, 5 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for DXCM stock is Buy.
Expert Analysis
According to DXCM short-term and long-term forecast, DexCom, Inc. shares are projected to go down by 99.11%, and reach a value of $0.79 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 57.142857142857146, which signals Greed. Also, DXCM has recorded 12/30 green days, which reflects a 54.54545454545454% positivity rate with a price volatility of 0.02%.
Plus, Price-to-Earnings (P/E) ratio of 62.725353 suggests that DXCM stock is overvalued. So, Based on DXCM prediction and analysis, it may be the best time to hold DXCM stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "DXCM” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.